Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Carcinoma of bladder
|
309 | 0.585 | 0.560 | 3 | 14158387 | missense variant | G/A | snv | 0.24 | 0.21 | 0.100 | 1.000 | 10 | 2006 | 2016 | ||||
Malignant neoplasm of urinary bladder
|
316 | 0.585 | 0.560 | 3 | 14158387 | missense variant | G/A | snv | 0.24 | 0.21 | 0.100 | 1.000 | 10 | 2006 | 2016 | ||||
Bladder Neoplasm
|
281 | 0.585 | 0.560 | 3 | 14158387 | missense variant | G/A | snv | 0.24 | 0.21 | 0.090 | 1.000 | 9 | 2006 | 2016 | ||||
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP C
|
82 | 0.585 | 0.560 | 3 | 14158387 | missense variant | G/A | snv | 0.24 | 0.21 | 0.090 | 0.889 | 9 | 2008 | 2019 | ||||
Breast Carcinoma
|
2793 | 0.585 | 0.560 | 3 | 14158387 | missense variant | G/A | snv | 0.24 | 0.21 | 0.050 | 1.000 | 5 | 2008 | 2019 | ||||
Colorectal Carcinoma
|
1962 | 0.585 | 0.560 | 3 | 14158387 | missense variant | G/A | snv | 0.24 | 0.21 | 0.050 | 0.800 | 5 | 2011 | 2015 | ||||
Malignant neoplasm of breast
|
3417 | 0.585 | 0.560 | 3 | 14158387 | missense variant | G/A | snv | 0.24 | 0.21 | 0.050 | 1.000 | 5 | 2008 | 2019 | ||||
Malignant Neoplasms
|
1641 | 0.585 | 0.560 | 3 | 14158387 | missense variant | G/A | snv | 0.24 | 0.21 | 0.050 | 1.000 | 5 | 2008 | 2019 | ||||
Primary malignant neoplasm
|
1374 | 0.585 | 0.560 | 3 | 14158387 | missense variant | G/A | snv | 0.24 | 0.21 | 0.050 | 1.000 | 5 | 2008 | 2019 | ||||
Carcinoma of lung
|
1204 | 0.585 | 0.560 | 3 | 14158387 | missense variant | G/A | snv | 0.24 | 0.21 | 0.040 | 0.500 | 4 | 2012 | 2014 | ||||
Malignant neoplasm of lung
|
1142 | 0.585 | 0.560 | 3 | 14158387 | missense variant | G/A | snv | 0.24 | 0.21 | 0.040 | 0.500 | 4 | 2012 | 2014 | ||||
Primary malignant neoplasm of lung
|
981 | 0.585 | 0.560 | 3 | 14158387 | missense variant | G/A | snv | 0.24 | 0.21 | 0.040 | 0.500 | 4 | 2012 | 2014 | ||||
Malignant neoplasm of colon and/or rectum
|
502 | 0.585 | 0.560 | 3 | 14158387 | missense variant | G/A | snv | 0.24 | 0.21 | 0.020 | 1.000 | 2 | 2014 | 2015 | ||||
Malignant neoplasm of skin
|
38 | 0.585 | 0.560 | 3 | 14158387 | missense variant | G/A | snv | 0.24 | 0.21 | 0.020 | 1.000 | 2 | 2012 | 2015 | ||||
Malignant neoplasm of stomach
|
615 | 0.585 | 0.560 | 3 | 14158387 | missense variant | G/A | snv | 0.24 | 0.21 | 0.020 | 0.500 | 2 | 2014 | 2016 | ||||
Nasopharyngeal carcinoma
|
320 | 0.585 | 0.560 | 3 | 14158387 | missense variant | G/A | snv | 0.24 | 0.21 | 0.020 | 1.000 | 2 | 2008 | 2017 | ||||
Stomach Carcinoma
|
652 | 0.585 | 0.560 | 3 | 14158387 | missense variant | G/A | snv | 0.24 | 0.21 | 0.020 | 0.500 | 2 | 2014 | 2016 | ||||
Azoospermia
|
70 | 0.585 | 0.560 | 3 | 14158387 | missense variant | G/A | snv | 0.24 | 0.21 | 0.010 | 1.000 | 1 | 2009 | 2009 | ||||
Bilateral cataracts (disorder)
|
37 | 0.585 | 0.560 | 3 | 14158387 | missense variant | G/A | snv | 0.24 | 0.21 | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||
Carcinoma of larynx
|
65 | 0.585 | 0.560 | 3 | 14158387 | missense variant | G/A | snv | 0.24 | 0.21 | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||
Cataract
|
124 | 0.585 | 0.560 | 3 | 14158387 | missense variant | G/A | snv | 0.24 | 0.21 | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||
Central neuroblastoma
|
231 | 0.585 | 0.560 | 3 | 14158387 | missense variant | G/A | snv | 0.24 | 0.21 | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||
Childhood Neuroblastoma
|
231 | 0.585 | 0.560 | 3 | 14158387 | missense variant | G/A | snv | 0.24 | 0.21 | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||
Diabetes
|
710 | 0.585 | 0.560 | 3 | 14158387 | missense variant | G/A | snv | 0.24 | 0.21 | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||
Diabetes Mellitus
|
824 | 0.585 | 0.560 | 3 | 14158387 | missense variant | G/A | snv | 0.24 | 0.21 | 0.010 | 1.000 | 1 | 2016 | 2016 |